Inozyme Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inozyme Pharma, Inc.
CIK #0001693011
EDGAR Form CIK 2011 - 2025
10-K [0001693011]
10-Q [0001693011]
3 [0001693011]
4 [0001693011]
8-K [0001693011]
D [0001693011]
SC 13D [0001693011]
SC 13G [0001693011]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC Inozyme Pharma Inc [2025-06-04]
Beryl Capital Management LLC Inozyme Pharma Inc [2025-05-23]
Affinity Asset Advisors LLC Inozyme Pharma Inc [2024-12-09]
BlackRock Inc Inozyme Pharma Inc [2024-11-08]
BlackRock Inc Inozyme Pharma Inc [2024-10-24]
Eventide Asset Management LLC Inozyme Pharma Inc [2024-02-14]
Samlyn Capital LLC Inozyme Pharma Inc [2024-02-14]
Millennium Management LLC Inozyme Pharma Inc [2023-05-31]
Sphera Funds Management Ltd Inozyme Pharma Inc [2023-03-07]
Baker Bros Advisors LP Inozyme Pharma Inc [2023-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Inozyme Pharma, Inc.
Subramanian Sanjay
Hopfner Robert Lorne
Treco Douglas A
Sullivan Lynne Marie
Bolte Axel
Winton Matthew
Harris Erik
Diaz Reinaldo M
Edwards Martin
View All
Terms | Privacy | Guide
tony@aum13f.com